In a decision dated the 24th of November, 2011 the Intellectual Property Appellate Board (IPAB) revoked patent number 193899 bearing title “Process for Preparation of Low Glycemic Sweets”. (This order can be accessed over here) As the title suggests the patent in question was for a process to prepare ‘low-sugar’ sweets for diabetic patients. The revocation petition was a part of a long-standing dispute between the famous Chennai based Adyar Bhavan and the inventors of the impugned patent. The first limb of this litigation was a suit for patent infringement filed before the Madras High Court by the inventors of the patent. At the interim stage the Madras High Court avoided examining questions of patent validity and proceeded to grant the plaintiffs an interim injunction. That order can be accessed over here. (Image from here) Sunday, February 19, 2012
Revoking patents without ‘evidence’
In a decision dated the 24th of November, 2011 the Intellectual Property Appellate Board (IPAB) revoked patent number 193899 bearing title “Process for Preparation of Low Glycemic Sweets”. (This order can be accessed over here) As the title suggests the patent in question was for a process to prepare ‘low-sugar’ sweets for diabetic patients. The revocation petition was a part of a long-standing dispute between the famous Chennai based Adyar Bhavan and the inventors of the impugned patent. The first limb of this litigation was a suit for patent infringement filed before the Madras High Court by the inventors of the patent. At the interim stage the Madras High Court avoided examining questions of patent validity and proceeded to grant the plaintiffs an interim injunction. That order can be accessed over here. (Image from here)
Posted by
Prashant Reddy
at
10:49 AM
0
comments
Links to this post
Labels: Indian patent litigation, IPAB, Patent
Saturday, February 18, 2012
MNC's Trademark revoked for Non-Use on Indian User's Application
Name of the Case: M/s. Pops Food Products (P) Ltd. (Petitioner) vs. M/s. Kellogg Company (Respondent) [TRA/159/2004/TM/DEL]
Decided on: January 6, 2012.
Facts of the Case: Petitioner is the proprietor of the trademark POPS under Nos. 342674, 342675, 342676 in classes 30, 29 and 30 respectively for its goods viz. Chewing Gum, Bubble Gum, Dairy Products etc. and has acquired a goodwill for itself through usage and advertisement of such mark for a long period of time, so as to have created a general public perception of the mark being associated with its goods. Respondent had intimated the Petitioner of it being the proprietor of trademark POPS in relation to cereal derived breakfast food and of its intention to oppose the Petitioner’s registration, and possibilities of settlement provided the Petitioner restricted its goods to specified goods. The Petitioner in turn has sought rectification by removal of Respondent’s mark from the Register.
Petitioner’s contentions: Respondent has not made any use of the mark in India nor does it have bona fide intention to do so. Although the products for which the marks are used are not identical, yet they are all bought across the country through the same trade channel and by the same class of customers, who, especially children, would be inclined to buy POPS Cereals thinking that the mark belongs to the manufacturer of Bubble Gum and Chewing Gum with whom they are familiar. The Petitioner also submitted conclusive documentary evidence to prove that POPS Chewing Gum and Double Bubble Gum are sold across the country.
Respondent’s contentions: The Respondent argued that the Petitioner had not proven continuous use of the mark POPS, while the Respondent had adopted the mark (the marks CORN POPS-638273, COCO POPS-758864, SNAP, CRACKLE, POP-345988, POP-TARTS-516460) in 1941 internationally and gained subsequent good will by its use. Although Respondent is yet to use its mark in India, the latter has gained parallel reputation and trans-border goodwill owing to Indians travelling abroad and the Respondent intends to use the mark subsequently in India. Moreover, Petitioner’s use of the mark being limited to products like Chewing Gums and Bubble Gums only, the Petitioner cannot have any cause for grievance against the Respondent since there is no scope of mistaking the Respondent’s products for the Petitioner’s.
The Respondent also cited several cases such as:
Jupiter Infosys Limited vs. Infosys Technologies Limited (In TRA/25-27/2003/TM/CH) [stating that in case of proving non-use, in the present day world of commerce and industry a manufacturing industry can neither be commenced nor established over night];
Revlon vs. Rajendra Kumar Dhawan [the initial onus of proving non-user is to be established by applicant for rectification through cogent evidence];
Kamat Hotels (India) Limited vs. Royal Orchid Hotels Limited (In ORA 216-217/2008/TM/CH) [stating that law requires proof of both no bonafide intention to use and no bonafide use];
Osram Gesellschaft Mit Beschrankter Haftung Vs. Shyam Sunder & Ors. (2002 (25) PTC 198 (Del) (DB) [a registered trade mark holder cannot in law claim exclusive monopoly rights for its trade mark as extended to goods of all descriptions falling within the same class in which its sole and solitary product falls.];
Hardie Trading Limited and Anr. Vs. Addisons Paint and Chemicals Limited (2003 (27) PTC 241(SC)) [In cases of rectification on the grounds of non-use, there was no reason to limit the user to use on the goods or to sale of goods bearing the trademark].
Judgment: Reference was made to the Milment Oftho Industries case [2004 (28) PTC 585 (SC)], wherein the Supreme Court had held earlier that in case of conflict between usage of a mark by a company within India and off-shore use by another company, public interest must not be imperilled, although multinational corporations, who have no intention of coming to India or introducing their product in India should not be allowed to throttle an Indian Company by not permitting it to sell a product in India, if the Indian Company has genuinely adopted the mark and developed the product and is first in the market. Thus, the ultimate test should be who is first in the market. The judiciary also showed considerable insight in concluding that while the Respondent’s contention that business cannot be started overnight has merit and that the person who alleges non-user (in this case the Petitioner) should bear the burden of proof, yet in this case, given the Respondent’s admission of non-use till date, the Petitioner needs not submit additional proof of the same. Nor did the Court find any bona fide intention of use of the mark by the Respondent within India, given how no step had been taken towards the same within the 22 years since the date on which the Respondent had registered said marks.
Order: The Petitioner’s contentions for rectification are accepted and the Respondent’s marks are ordered to be removed from the Trademark Register.
Posted by
Shouvik Kumar Guha
at
11:39 AM
2
comments
Links to this post
Labels: revocation, Shouvik Kumar Guha, SpicyIP Cases, Trademark
Friday, February 17, 2012
No patent for Bristol's infant formula at the IPO: 4807/CHENP/2006
The patent office may, therefore, reject an application because of no support in originally filed complete application, but it cannot reject an application merely because claims have been suitably amended to comply with jurisdictional norms. Claim amendments that comply with jurisdictional norms must, in my view, be encouraged. Warning: Long post follows:
Therefore the Controller refused to allow the application.
Posted by
Rajiv Kr. Choudhry
at
8:46 PM
3
comments
Links to this post
Labels: Controller's decisions, Patent, patent agent exam, Patent Prosecution, Patent Strategies, Pharma, Rajiv
More on the nationalization of GIs - Sarkar Raj - Power cannot be given - It has to be taken
A total of 17 G.I.s for handicrafts have been registered by Development Commissioner (Handicrafts), Ministry of Textiles, Government of India. Amongst the various G.I. granted to this agency are the ‘Coconut Shell Crafts of Kerala’, ‘Temple Jewellery of Nagercoli’, ‘Kathputlis of Rajasthan’, ‘Leather Toys of Indore’ and ‘Bagh Prints of Madhya Pradesh’. The Development Commissioner sitting in Delhi has therefore registered G.I.s for handicrafts across the length and breadth of the country. The only way the Development Commissioner could have filed these applications is if he claimed to have been representing the interests of the producers of these handicrafts. I have no clue whether the Development Commissioner for Handicrafts was actually authorized under the law to represent the interests of the artisans who make these handicrafts. Image right: Madhubani Paintings - Image from here.
Posted by
Prashant Reddy
at
2:20 PM
10
comments
Links to this post
Labels: Geographical Indication
Wednesday, February 15, 2012
‘NO’ to Monsanto: Indian NGO Complains Bio-piracy before the EPO over a Resistant Melon Variety
Indian scientist and environmentalist Dr. Vandana Shiva has joined hands with ‘No Patents on Seeds’ coalition in their opposition to a patent granted by the European Patent Office (EPO) in May last year to Monsanto Invest N.V. over ‘closterovirus-resistant melon plant’. The patent claims a new variety of melon which is resistant to Curcurbit Yellow Stunting Disorder Virus (CYSDV) bred using closterovirus-resistant trait identified in few melons of Indian origin. The Indian variety has long been registered in international seed banks (PI 313970) and the claim according to opponents uses conventional breeding methods of crossing and selection to create the new resistant varieties.
Image from here
The opponents seek complete revocation of the patent for lack of inventiveness and have pointed out that conventional breeding methods are beyond the scope of patentability under Article 53(b) of the European Patent Convention, 1973. Furthermore, they allege that the application does not sufficiently and clearly disclose information required to breed CYSDV resistant melons. More importantly, the opponents fear that the patent would deny ‘access to genetic resources necessary for further breeding’. In this regard, Dr. Shiva’s Navdanya argues that the claim is not patentable under Article 53(a) as it is against ordere public for violating provisions of the Indian Biological Diversity Act, 2002 enacted pursuant to Convention on Biological Diversity (CBD).
Bio-piracy of Indigenous Melons
Dr. Shiva’s Navdanya has deposed that Monsanto’s patent violates the following domestic biodiversity and plant variety legislations for not obtaining prior approval from the Indian Government:
(i) Biological Diversity Act, 2002: Section 6 of the Act mandates approval from the National Biodiversity Authority (NBA) for acquiring a patent right anywhere over an invention based on biological resources obtained from India. Given that Monsanto did not obtain any permission from the NBA and Indian melon varieties were used in creating the new variety, they can be prosecuted under the Act for bio-piracy.
(ii) Protection of Plant Varieties & Farmers’ Rights Act, 2001: The subject matter of the Act deals with granting and protecting rights of farmers and breeders of new plant varieties. The Act, however, nowhere imposes any obligation on breeders’ to seek permission from the Plant Varieties Authority before seeking an IP right over new varieties bred using indigenous biological resources. In fact, Section 30 permits all breeders to use any extant variety for creating new varieties without conflicting with other rights. Even otherwise, the Act is territorially limited to protection of new plant varieties domestically and it would not be sufficient to deny a patent abroad. Hence, I see no violation of sovereign rights under the Act.
What are they actually trying to oppose?
Posted by
Sai Vinod
at
9:19 PM
4
comments
Links to this post
Sunday, February 12, 2012
The ‘Nationalization’ of Geographical Indications in India
Moving on to some of the other instances, I have to say that most of these registrations appear to be rather odd. For example the G.I. Application (No. 169) for the famous ‘Kolhapuri Chappals’ which is usually manufactured in the Kolhapur District of Maharashtra has been filed by the Central Leather Research Institute (a part of CSIR) located in Chennai i.e. at least a thousand kilometres from Maharashtra. The ‘Kolhapuri Chappals’ are really famous because of the efforts of traditional artisans over the years. Why then is CSIR filing a GI Application for this particular G.I.? Why aren’t the artisans of Kolhapur filing this application in the name of their own association? Image right: 'Kolhapuri Chappals' from here.
Posted by
Prashant Reddy
at
2:52 PM
4
comments
Links to this post
Labels: Geographical Indication
Official Inquiry into mismanagement of IPRS given a quiet burial
Posted by
Prashant Reddy
at
1:06 AM
3
comments
Links to this post
Labels: Copyright, Copyright Amendment Bill 2010, Copyright Societies, IPRS, ppl
Saturday, February 11, 2012
Controller's Decisions: Summary January 2012
|
APPLICATION #
|
APPLICANT
|
DECISION
|
SECTION/RULE
|
CONTROLLER
|
|
BOEHRINGER
|
Refused
|
3(d), 2(1)(j)
|
N.R.Meena
|
|
|
CSIR
|
Deemed withdrawn
|
R11B
|
N.R.Meena
|
|
|
ENI .p.A.
|
Time extended
|
77(1)(g)
|
Shah Alam
|
|
|
BAXTER
|
Refused
|
2(1)(j/a); 10(4b)
|
Dr.Rajesh Dixit
|
|
|
BRISTOL-MYERS
|
Refused
|
10(4)
|
Dr Subramaniyan
|
|
|
I. N. S. E. R. M.
|
Refused
|
15
|
Shah Alam
|
|
|
TELECOM ITALIA
|
Allowed
|
3(k)
|
B.P.Singh
|
|
|
TRIDENT SCIENCES
|
Refused
|
15
|
Shah Alam
|
|
|
NETOMAT,INC.,
|
Refused
|
3(k)
|
B.P.Singh
|
|
|
LES LABORATOIRES
|
Refused
|
3(d), 3(e)
|
N.R.Meena
|
|
|
Dr. Reddy & Anr.
|
Refused
|
2(1)(j), 15
|
S Thangapandian
|
|
|
EMSENSE
|
Refused
|
11B(4)
|
Dr.K.S.Kardam
|
|
|
CARLOS, ALBERTO
|
Refused
|
11B(4)
|
Dr.K.S.Kardam
|
|
|
NAPO PHARMA
|
Refused
|
3(e), 15
|
Dr Subramaniyan
|
Posted by
Rajiv Kr. Choudhry
at
1:32 AM
16
comments
Links to this post
Labels: 3(d), 3(e), 3(k), Controller's decisions, Patent, patent agent exam, Patent Prosecution, Patent Strategies, Rajiv
Thursday, February 09, 2012
SpicyIP Event: Global Pharma Regulatory Summit India 2012, Mumbai
This event comes specially for those of you interested in pharma regulation, from the same folks who organised the Pharma IPR Summit recently. The organisers send us the following details. Please don't forget to mention that you came via SpicyIP.
Event Name: Global Pharma Regulatory Summit India 2012
Dates: 28 Feb - 2 March 2012 [individually bookable days]
Venue: Holiday Inn Mumbai International Airport, Mumbai, India
URL: www.pharmaregulation-india.com
Contact Person: Ms Asan Bano
Contact Number: +91 (022) 4046 1466
Contact Email: conferences-india@ubm.com
---
India tops US $11 billion global generics export list
Global regulatory compliance is by far the biggest factor related to success, as pharmaceutical companies look to exploit the increasing demand of Indian generics in key export markets.
Join 120+ heads, executives, managers and team leaders of Regulatory Affairs, Quality Assurance, Quality Control and more at the Pharma Regulatory business conference and learn implementable strategies to support efficient approvals of your Indian generics in key export hot-spots.
Book for the day of your choice by registering online, or contacting Ms Asan Bano on +91 (022) 4046 1466 or conferences-india@ubm.com today!
Special offer for SPICY IP readers!
Our early bird discount packages that expired on 3 Feb, is now open only to SPICY IP subscribers!
Don’t miss – register quoting “SPICYIP” & take advantage of our special discounts valid until 24 Feb!
Region focused agenda:
(a) 29 Feb: US regulations - Learn practical insights to ensure flawless submissions for:
- DMF and ANDA filing procedures
- CTD and ECTD submissions
- Variation handling process
- Critical pharmacovigilance requirements
- Approval of 505 (b)(2) applications
- Dosage based deficiencies
(b) 1 March: EU regulations - Gain in-depth insights through live examples and comprehensive query handling sessions on:
- Stability and impurity profiling requirements
- Generic drug application filing procedure
- Post approval supplements
- Variation guidelines
- Requirements for hybrid applications in the EU
(c) 2 March: India, Japan and ROW regulations - Understand and overcome complexities involved in gaining swift regulatory approvals for DMF and generic applications in:
- India
- Japan
- Latin America
- Australia
- Russia
- China
- South Africa
To register and benefit from early bird discounts, please contact Ms Asan Bano on +91 (022) 4046 1466 or email conferences-india@ubm.com today!
Posted by
Sumathi Chandrashekaran
at
9:31 PM
0
comments
Links to this post
Labels: Drug Regulation, Indian Pharma, Pharma, SpicyIP Events





